United States: Zubillaga V. Allstate Indemnity Company

In Zubillaga v. Allstate Indemnity Company, 12 Cal.App.5th1017, the Court of Appeal of California, Fourth Appellate District reversed the trial court's grant of summary judgment to Allstate, finding there were triable issues of material fact regarding whether Allstate's coverage determination was made without a good faith investigation and without a reasonable basis for a genuine dispute.

Plaintiff had an automobile policy with Allstate that included UIM coverage with a $50,000 per person limit, to be reduced by any amounts paid by the owner or operator of the underinsured car, and provided for voluntary binding arbitration. Plaintiff was in a serious accident, for which the police determined the other driver was at fault. According to the police report, Plaintiff complained of pain to her face and arm, and did not report any back injury or back pain. Instead of following up with her own doctor, she saw a chiropractor – 39 times over the following four months. Plaintiff also saw an osteopath who determined a MRI of Plaintiff's cervical spine indicated multiple disc protrusions, which would likely require future medical treatment. Plaintiff's attorney made a demand on Allstate for $35,000 (the policy limit after deducting the other driver's $15,000 settlement), based on her current medical bills of $17,645.44 and lower back pain for the remainder of her life expectancy. Allstate offered to settle the matter for $9,367, which it calculated by taking its determination of the reasonable and customary amount for Plaintiff's medical bills ($14,367), adding $10,000 in general damages, then subtracting the $15,000 settlement from the other driver. The next day, Plaintiff served a formal offer to compromise (per Section 998) for $35,000; Plaintiff did not otherwise respond to Allstate's offer for more than four months, at which point Plaintiff's counsel formally rejected the offer and again demanded $35,000, providing two evaluations by a board certified orthopedic surgeon. These evaluations increased Plaintiff's medical expenses by $1,200, and did not reference any need for epidural steroid injections. Allstate increased its evaluation of the claim to $25,000 due to Plaintiff's continuing complaints of back pain; Allstate increased its settlement offer to $10,000. Plaintiff's counsel rejected this offer, renewed her $35,000 demand, demanded arbitration, and requested Allstate assign counsel to handle the claim. Allstate assigned counsel, and served written discovery. Plaintiff's responses to the written discovery reference a consultation with a board certified pain management specialist and anesthesiologist, and both he and the osteopath opined she will require epidural injections, anti-inflammatory and pain medication, and physical therapy. Plaintiff's counsel sent Allstate Plaintiff's medical records from the pain management specialist, who diagnosed Plaintiff with lumbar disc herniation and opined the information provided is consistent with the car accident as the cause of her pain. The specialist also opined Plaintiff would need lumbar epidural steroid injections, which would range from $15,000-20,000 for one to $45,000-60,000 for three. Allstate increased its valuation to $27,084, offering Plaintiff $12,084. Allstate also retained a board certified orthopedic surgeon to perform a defense medical examination, review the medical records, and determine if the injections were appropriate. The surgeon provided three reports, which disagree as to the necessity of the injections. 

Plaintiff's counsel requested arbitration set for at least three months out, to accommodate Plaintiff being scheduled to receive an injection in the following weeks. Allstate responded, and requested any new records and bills for review and re-evaluation prior to the arbitration date. Allstate received additional medical records, supporting an additional claim of $6,850 in medical expenses for a steroid injection. With this new expense, Plaintiff's medical bills totaled $26,455.44; Allstate offered $14,500. Plaintiff's counsel provided a report from the doctor who administered the steroid injection, opining Plaintiff may need an additional three injections (costing $12,000 each) in conjunction with medications and physical therapy, each of which would likely cost $6,000 per year. Allstate did not have its expert review this report, but instead increased the valuation to $30,584, and offered $15,584.

During arbitration, Plaintiff produced an additional report from her doctor who had provided the injections, which had not been provided to Allstate before, that Plaintiff argued proved future injections were necessary and appropriate. The arbitrator found for Plaintiff, awarding her $35,000 ($21,205 in economic damages, and $13,795 in non-economic damages). Allstate paid the arbitration award. 

Plaintiff sued Allstate for breach of contract and bad faith, claiming Allstate "did not fairly investigate her claim and should have paid her the UIM policy limits sooner." The trial court granted Allstate's motion for summary judgment as to Plaintiff's bad faith cause of action on the genuine dispute doctrine, finding "Defendant Allstate was permitted to rely on its expert's opinion, who had a history of all of Plaintiff's treating doctors [ . . . ] to determine that her treatment was excessive and she did not need the expensive steroid injections." 

The Court reviewed California law regarding the implied covenant of good faith and fair dealing, including that an insurer cannot ignore available evidence supporting a claim in favor of facts justifying denial. However, an insurer is not liable for a failure to pay or delay in paying policy benefits where there is a genuine dispute as to coverage, which applies to both legal and factual disputes. An insurer is only entitled to a grant of summary judgment on this basis "where the summary judgment record demonstrates the absence of triable issues [citation] as to whether the disputed position upon which the insurer denied the claim was reached reasonably and in good faith. [Citation.]." Determining whether a dispute is legitimate is an objective standard, and must be evaluated as of the time the decisions were made, and not in light of any subsequent events showing error. Additionally, there may be a basis for application of the genuine dispute doctrine where the insurer relies on the advice of experts – although reliance on expert advice does "not automatically insulate an insurer from a bad faith claim." 

The Court noted the problem with Allstate's reliance on its expert: the expert rendered his opinions in October and November 2012, yet Allstate continued to rely on the opinions through arbitration in September 2013, without consulting him again or conducting further investigation, particularly as to the injections Plaintiff was receiving. 

Because it never asked Legome [Allstate's expert] to review Soni's [the doctor administering the injections] epidural treatments and recommendations, Allstate's continued reliance upon Legome's opinions as the basis for disputing the medical necessity or reasonable value of those treatments and recommendations may have been unreasonable. And, leaving aside Legome's reports and opinions, Allstate has not directed us to any other medical reports or opinions that could reasonably support its ongoing denial of plaintiff's claim.

Of course, Allstate was not obliged to accept Soni's treatments and recommendations "without scrutiny or investigation." [Citation.] To the extent it had good faith doubts, Allstate had the right to further investigate the basis for plaintiff's claim by having Legome reexamine his 2012 opinions, having another physician review all of plaintiff's medical records and offer opinions, or, if necessary, having plaintiff further examined by Legome or another defense doctor.

What Allstate could not do, consistent with the implied covenant of good faith and fair dealing, was to ignore Soni's treatments and recommendations, without adequately investigating them. [Citation.] To be clear, we are not saying Allstate breached the implied covenant. We are saying a reasonable jury could conclude it did so. Allstate's assertion it reasonably continued to rely on Legome's opinions, or that it had inadequate time to have him reexamine those opinions or conduct further investigation, merely inform our conclusion plaintiff has demonstrated triable issues of material fact that cannot be resolved by summary judgment.

For these same reasons, the court erred by granting summary judgment based upon the genuine dispute doctrine. Again, the genuine dispute rule does not relieve an insurer from its obligation to thoroughly and fairly investigate the insured's claim, and a genuine dispute exists only where the insurer's position is maintained in good faith and on reasonable grounds. Once more, an insurer is not entitled to judgment as a matter of law where, viewing the facts in the light most favorable to the plaintiff, a jury could conclude that the insurer acted unreasonably. [Citation.]

Considering the objective facts known to Allstate at the time its final decision to deny plaintiff's $35,000 demand was made, and viewing the evidence in the light most favorable to plaintiff as required, we are convinced "'a jury could conclude that the insurer acted unreasonably.'" [Citation.] Specifically, there is sufficient evidence for a jury to find Allstate's continued insistence she did not need expensive epidural injections was, "'"prompted not by an honest mistake, bad judgment or negligence but rather by a conscious and deliberate act, which unfairly frustrates the agreed common purposes and disappoints the reasonable expectations of the other party thereby depriving that party of the benefits of the agreement."'" [Citation.]

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Authors
 
In association with
Related Topics
 
Related Articles
 
Related Video
Up-coming Events Search
Tools
Print
Font Size:
Translation
Channels
Mondaq on Twitter
 
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
 
Email Address
Company Name
Password
Confirm Password
Position
Mondaq Topics -- Select your Interests
 Accounting
 Anti-trust
 Commercial
 Compliance
 Consumer
 Criminal
 Employment
 Energy
 Environment
 Family
 Finance
 Government
 Healthcare
 Immigration
 Insolvency
 Insurance
 International
 IP
 Law Performance
 Law Practice
 Litigation
 Media & IT
 Privacy
 Real Estate
 Strategy
 Tax
 Technology
 Transport
 Wealth Mgt
Regions
Africa
Asia
Asia Pacific
Australasia
Canada
Caribbean
Europe
European Union
Latin America
Middle East
U.K.
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.

Disclaimer

The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.

General

Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions